Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
about
Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies.Advances in NSAID development: evolution of diclofenac products using pharmaceutical technologyLow-dose SoluMatrix diclofenac : a review of safety across two Phase III studies in patients with acute and osteoarthritis pain.Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study.Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial.SoluMatrix® Diclofenac: Sustained Opioid-Sparing Effects in a Phase 3 Study in Patients with Postoperative Pain.Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage.
P2860
Q33845573-D338CFB7-1281-4D68-9336-08996985127DQ34475981-C13E8E14-C167-4F11-A403-002819AFEC6BQ34669949-82B26D80-4079-4CF7-BCE9-0076B7DB9DCDQ38412511-E41426E6-AD8E-464C-A6DE-48BBE5746A93Q39159788-7C8B8EE7-E9AC-4786-8105-8A0BFD2DD187Q44335962-73C420DD-B404-46A6-8B3A-A953002166C7Q48166311-8A1DDEDB-E350-4282-849A-C4CD4ACE7741
P2860
Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
@en
Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
@nl
type
label
Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
@en
Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
@nl
prefLabel
Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
@en
Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
@nl
P2093
P1476
Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
@en
P2093
Clarence L Young
Daniel Solorio
Kemi Olugemo
Paul J Desjardins
P304
P356
10.1016/J.CLINTHERA.2014.10.018
P577
2014-12-08T00:00:00Z